204 related articles for article (PubMed ID: 26062933)
21.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
22. [(18)F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma.
Withofs N; Martinive P; Vanderick J; Bletard N; Scagnol I; Mievis F; Giacomelli F; Coucke P; Delvenne P; Cataldo D; Gambhir SS; Hustinx R
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):654-62. PubMed ID: 26490751
[TBL] [Abstract][Full Text] [Related]
23. Pilot-phase PET/CT study targeting integrin α
Nakamoto R; Ferri V; Duan H; Hatami N; Goel M; Rosenberg J; Kimura R; Wardak M; Haywood T; Kellow R; Shen B; Park W; Iagaru A; Gambhir SS
Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):184-193. PubMed ID: 34729628
[TBL] [Abstract][Full Text] [Related]
24. ¹⁸F-FPRGD₂ PET/CT imaging of musculoskeletal disorders.
Withofs N; Charlier E; Simoni P; Alvarez-Miezentseva V; Mievis F; Giacomelli F; Mella C; Gambhir SS; Malaise O; de Seny D; Malaise M; Hustinx R
Ann Nucl Med; 2015 Dec; 29(10):839-47. PubMed ID: 26254227
[TBL] [Abstract][Full Text] [Related]
25. Physiological uptake values of 18F-FDG in long bones of the lower extremity on PET/CT imaging.
van Vliet KE; van Eck-Smit BL; de Jong VM; Goslings JC; Schep NW; Termaat MF
Nucl Med Commun; 2016 Jun; 37(6):589-92. PubMed ID: 26849073
[TBL] [Abstract][Full Text] [Related]
26. Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide.
Meisetschläger G; Poethko T; Stahl A; Wolf I; Scheidhauer K; Schottelius M; Herz M; Wester HJ; Schwaiger M
J Nucl Med; 2006 Apr; 47(4):566-73. PubMed ID: 16595488
[TBL] [Abstract][Full Text] [Related]
27. Pilot study of FPPRGD2 for imaging α(v)β(3) integrin--how integral are integrins?
Choyke PL
Radiology; 2011 Jul; 260(1):1-2. PubMed ID: 21697304
[TBL] [Abstract][Full Text] [Related]
28. Effect of blood glucose level on standardized uptake value (SUV) in
Eskian M; Alavi A; Khorasanizadeh M; Viglianti BL; Jacobsson H; Barwick TD; Meysamie A; Yi SK; Iwano S; Bybel B; Caobelli F; Lococo F; Gea J; Sancho-Muñoz A; Schildt J; Tatcı E; Lapa C; Keramida G; Peters M; Boktor RR; John J; Pitman AG; Mazurek T; Rezaei N
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):224-237. PubMed ID: 30350009
[TBL] [Abstract][Full Text] [Related]
29. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
[TBL] [Abstract][Full Text] [Related]
30. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
[TBL] [Abstract][Full Text] [Related]
31. Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice.
Lang L; Li W; Guo N; Ma Y; Zhu L; Kiesewetter DO; Shen B; Niu G; Chen X
Bioconjug Chem; 2011 Dec; 22(12):2415-22. PubMed ID: 22026940
[TBL] [Abstract][Full Text] [Related]
32. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
[TBL] [Abstract][Full Text] [Related]
34. Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor.
Takemoto K; Hatano E; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Yamauchi H; Matsumura K; Zaima M; Toriguchi K; Tanabe K; Kitamura K; Seo S; Taura K; Endo K; Uemoto S; Higashi T
Ann Nucl Med; 2014 May; 28(4):371-80. PubMed ID: 24599824
[TBL] [Abstract][Full Text] [Related]
35. Inter-heterogeneity and intra-heterogeneity of α
Kang F; Wang Z; Li G; Wang S; Liu D; Zhang M; Zhao M; Yang W; Wang J
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1520-1528. PubMed ID: 28405726
[TBL] [Abstract][Full Text] [Related]
36. Defining optimal tracer activities in pediatric oncologic whole-body
Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
[TBL] [Abstract][Full Text] [Related]
37. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
38. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
39. 18F-FDG uptake and clearance in patients with compromised renal function.
Akers SR; Werner TJ; Rubello D; Alavi A; Cheng G
Nucl Med Commun; 2016 Aug; 37(8):825-32. PubMed ID: 27058366
[TBL] [Abstract][Full Text] [Related]
40. Current generation time-of-flight (18)F-FDG PET/CT provides higher SUVs for normal adrenal glands, while maintaining an accurate characterization of benign and malignant glands.
Koopman D; van Dalen JA; Stigt JA; Slump CH; Knollema S; Jager PL
Ann Nucl Med; 2016 Feb; 30(2):145-52. PubMed ID: 26644009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
